Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Innodata Inc (INOD) vs Novavax Inc (NVAX) Price & Performance

Innodata IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Innodata Inc vs Novavax Inc — how do they compare? Innodata Inc trades at $64.49 (market cap $2.03B), while Novavax Inc trades at $8.08 (market cap $1.30B). The key difference: Innodata Inc is the larger of the two by market cap. Which is the better fit depends on your goals.

INODNVAX
Market Cap
$2.03B$1.30B
Sector
TechnologyHealth
52-Week High
$121.50$11.19
52-Week Low
$34.45$6.22
Enterprise Value
$1.91B$800.50M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Innodata Inc

No Aura AI signal available yet.

Novavax Inc

Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.

Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.

Returns comparison

Trailing returns across standard periods

About Innodata Inc

Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.

Read more on INOD

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX